國立高雄大學圖資館 |

Language: English

Back

Breast cancerfrom bench to personalized medicine /

Record Type:	Electronic resources : Monograph/item
Title/Author:	Breast canceredited by Saima Shakil Malik, Nosheen Masood.
Reminder of title:	from bench to personalized medicine /
other author:	Shakil Malik, Saima.
Published:	Singapore :Springer Nature Singapore :2022.
Description:	xvii, 536 p. :ill., digital ;24 cm.
Contained By:	Springer Nature eBook
Subject:	BreastCancer.
Online resource:	https://doi.org/10.1007/978-981-19-0197-3
ISBN:	9789811901973$q(electronic bk.)

Breast cancerfrom bench to personalized medicine /
Breast cancerfrom bench to personalized medicine /[electronic resource] :edited by Saima Shakil Malik, Nosheen Masood. - Singapore :Springer Nature Singapore :2022. - xvii, 536 p. :ill., digital ;24 cm.

Module 1_Overview of Breast Cancer -- Module 2_Cell and Molecular Biology of Breast Cancer-Diagnosis and Prognosis -- Module 3_Breast Cancer Treatment.

This book provides detailed information on the etiology, pathogenesis, diagnosis, prognosis, and treatment strategies for breast cancer. The first section of the book presents epidemiology, risk factors, histopathological, immunohistochemistry, and molecular subtypes of breast cancer based on the receptor status. It also discusses the association of breast cancer with other hormone-sensitive cancers. The second section of the book covers cover BRCA1 and BRCA2-associated breast carcinogenesis, early-stage progression of breast cancer, and noninvasive biomarkers for the early detection of breast cancer. It also discusses the role of epigenetic modifications and non-coding RNAs in breast cancer metastasis and explores these as the biomarkers and therapeutic targets for breast cancer therapy. Further, it discusses the role of fibrinolytic mechanisms and circulating tumor cells in breast cancer diagnosis, prognosis, and treatment. The book also provides an update on oral poly(ADP-ribose) polymerase (PARP) inhibitors to treat breast cancer. Finally, it offers potential new options for personalized therapies for breast cancer patients, including optimizing drug dosage and identifying genetic changes associated with cancer symptom occurrence and severity.

ISBN: 9789811901973$q(electronic bk.)

Standard No.: 10.1007/978-981-19-0197-3doiSubjects--Topical Terms:

275788
Breast
--Cancer.

LC Class. No.: RC280.B8

Dewey Class. No.: 616.9449

Breast cancerfrom bench to personalized medicine /
LDR:02428nmm a2200325 a 4500 001 620421
003 DE-He213
005 20220514091817.0
006 m d
007 cr nn 008maaau
008 221121s2022 si s 0 eng d
020 $a 9789811901973$q(electronic bk.)
020 $a 9789811901966$q(paper)
024 7 $a 10.1007/978-981-19-0197-3 $2 doi
035 $a 978-981-19-0197-3
040 $a GP $c GP
041 0 $a eng
050 4 $a RC280.B8
072 7 $a MJCL $2 bicssc
072 7 $a MED062000 $2 bisacsh
072 7 $a MJCL $2 thema
082 0 4 $a 616.9449 $2 23
090 $a RC280.B8 $b B828 2022
245 0 0 $a Breast cancer $h [electronic resource] : $b from bench to personalized medicine / $c edited by Saima Shakil Malik, Nosheen Masood.
260 $a Singapore : $b Springer Nature Singapore : $b Imprint: Springer, $c 2022.
300 $a xvii, 536 p. : $b ill., digital ; $c 24 cm.
505 0 $a Module 1_Overview of Breast Cancer -- Module 2_Cell and Molecular Biology of Breast Cancer-Diagnosis and Prognosis -- Module 3_Breast Cancer Treatment.
520 $a This book provides detailed information on the etiology, pathogenesis, diagnosis, prognosis, and treatment strategies for breast cancer. The first section of the book presents epidemiology, risk factors, histopathological, immunohistochemistry, and molecular subtypes of breast cancer based on the receptor status. It also discusses the association of breast cancer with other hormone-sensitive cancers. The second section of the book covers cover BRCA1 and BRCA2-associated breast carcinogenesis, early-stage progression of breast cancer, and noninvasive biomarkers for the early detection of breast cancer. It also discusses the role of epigenetic modifications and non-coding RNAs in breast cancer metastasis and explores these as the biomarkers and therapeutic targets for breast cancer therapy. Further, it discusses the role of fibrinolytic mechanisms and circulating tumor cells in breast cancer diagnosis, prognosis, and treatment. The book also provides an update on oral poly(ADP-ribose) polymerase (PARP) inhibitors to treat breast cancer. Finally, it offers potential new options for personalized therapies for breast cancer patients, including optimizing drug dosage and identifying genetic changes associated with cancer symptom occurrence and severity.
650 0 $a Breast $x Cancer. $3 275788
650 0 $a Breast $x Cancer $x Molecular aspects. $3 280479
650 0 $a Breast $x Cancer $x Treatment. $3 275791
650 1 4 $a Cancer Biology. $3 920982
650 2 4 $a Cancer Epidemiology. $3 921102
650 2 4 $a Cancer Genetics and Genomics. $3 918740
700 1 $a Shakil Malik, Saima. $3 859351
700 1 $a Masood, Nosheen. $3 859350
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer Nature eBook
856 4 0 $u https://doi.org/10.1007/978-981-19-0197-3
950 $a Biomedical and Life Sciences (SpringerNature-11642)